TXNIP and liver dysplastic nodule: Diabetic kidneys show elevated TXNIP expression, and inhibition of TXNIP attenuates high glucose-induced renal injury, positioning TXNIP as a potential target for DN therapy (Dai et al. 2021b; Wang et al. 2022a).